US Patent:
20050107588, May 19, 2005
Inventors:
Brendan Duggan - Sunnyvale CA, US
Junming Yang - San Jose CA, US
Kimberly Gietzen - San Jose CA, US
Soo Lee - Mountain View CA, US
Y. Tang - San Jose CA, US
Yalda Azimzai - Oakland CA, US
Narinder Chawla - Union City CA, US
Bridget Warren - San Marcos CA, US
Ines Barroso - Cambridge, GB
Shanya Becha - San Francisco CA, US
Henry Yue - Sunnyvale CA, US
Kavitha Thangavelu - Sunnyvale CA, US
Sally Lee - San Jose CA, US
Brooke Emerling - Chicago IL, US
Amy Kable - Silver Spring MD, US
Reena Khare - Saratoga CA, US
Mariah Baughn - Los Angeles CA, US
Ameena Gandhi - San Francisco CA, US
Uyen Tran - San Jose CA, US
Thomas Richardson - Redwood City CA, US
Joseph Marquis - San Jose CA, US
Preeti Lal - Santa Clara CA, US
Ian Forsythe - Edmonton, CA
Ernestine Lee - Kensington CA, US
Anita Swarnakar - San Francisco CA, US
Deborah Kallick - Galveston TX, US
Jennifer Griffin - Fremont CA, US
Vicki Elliott - San Jose CA, US
Ann Gorvad - Bellingham WA, US
April Hafalia - Daly City CA, US
Craig Ison - San Jose CA, US
Pei Jin - Palo Alto CA, US
Xin Jiang - Saratoga CA, US
Alan Jackson - Los Gatos CA, US
Umesh Bhatia - San Jose CA, US
John Burrill - Redwood City CA, US
Julie Blake - San Francisco CA, US
Anne Ho - Sunnyvale CA, US
Wenjin Zheng - San Diego CA, US
Jing Gao - Santa Clara CA, US
International Classification:
C07K014/705
C07H021/04
US Classification:
530350000, 435069100, 435320100, 435325000, 536023500
Abstract:
Various embodiments of the invention provide human receptors and membrane-associated proteins (REMAP) and polynucleotides which identify and encode REMAP. Embodiments of the invention also provide expression vectors, host cells, anti-bodies, agonists, and antagonists. Other embodiments provide methods for diagnosing, treating, or preventing disorders associated with aberrant expression of REMAP.
